Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL2518912 | 0.97 | FFAR3 (0.50) | FFAR3LCKFYNCA2CA1 | |
| Phosphoric Acid SCHEMBL2362458 | 0.93 | FFAR3 (0.54) | FFAR3LCKFYNCA2CA1 | |
| Phosphoric Acid SCHEMBL7034163 | 0.93 | FFAR3 (0.54) | FFAR3LCKFYNCA2CA1 | |
| Phosphoric Acid SCHEMBL29165565 | 0.90 | FFAR3 (0.50) | FFAR3LCKFYNCA2LMNA | |
| Phosphoric Acid SCHEMBL6844514 | 0.89 | FFAR3 (0.58) | FFAR3LCKFYNCA2CA1 | |
| Phosphoric Acid SCHEMBL28128431 | 0.89 | FFAR3 (0.58) | FFAR3LCKFYNCA2CA1 | |
| Phosphoric Acid SCHEMBL22400297 | 0.89 | FFAR3 (0.58) | FFAR3LCKFYNCA2CA1 | |
| Phosphoric Acid SCHEMBL1677253 | 0.89 | FFAR3 (0.58) | FFAR3LCKFYNCA2CA1 | |
| Phosphoric Acid SCHEMBL28092934 | 0.87 | FFAR3 (0.47) | FFAR3LCKFYNCA2CA1 | |
| Phosphoric Acid SCHEMBL31386590 | 0.86 | FFAR3 (0.54) | FFAR3LCKFYNCA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150183863-A1 | CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES | ABBVIE BIOTECHNOLOGY LTD (BM) | 2015-07-02 | — | — | US | disclosed |
| US-8772458-B2 | Crystalline anti-hTNFalpha antibodies | ABBVIE BIOTECHNOLOGY LTD (BM) | 2014-07-08 | — | — | US | disclosed |
| US-20130309309-A1 | CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES | ABBVIE BIOTECHNOLOGY LTD (BM) | 2013-11-21 | — | — | US | disclosed |
| US-8436149-B2 | Crystalline anti-hTNFalpha antibodies | ABBVIE BIOTECHNOLOGY LTD (BM) | 2013-05-07 | — | — | US | disclosed |
| US-20120251550-A1 | Crystalline anti-hTNFalpha antibodies | ABBOTT BIOTECHNOLOGY LTD. (BM) | 2012-10-04 | — | — | US | disclosed |
| US-8034906-B2 | Crystalline anti-hTNFalpha antibodies | ABBOTT BIOTECHNOLOGY LTD. (BM) | 2011-10-11 | — | — | US | disclosed |
| US-20100034823-A1 | Crystalline anti-hTNFalpha antibodies | ABBVIE BIOTECHNOLOGY LTD (BM) | 2010-02-11 | — | — | US | disclosed |